Stalevo
Utilized to manage neurological dysfunction to support motor control.
Strengths: 25/100/200mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Dopaminergic Agent
- Pharmacological class
Dopamine Precursor/COMT Inhibitor
- Minor side effects
dyskinesia; nausea; dizziness; chromaturia
- Moderate side effects
hallucinations; confusion; insomnia
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Patient summary
Utilized to manage neurological dysfunction to support motor control.
- Prescription status
POM
- Manufacturer
Orion Pharma
- Onset Time
0.5–2 hours
- Duration
3–6 hours
- Storage instructions
Keep container tightly closed and protect from light.
- Drug interactions
Iron supplements; Antipsychotics
- Age restrictions
Not for children.
- Pregnancy and breastfeeding
Pregnancy: not recommended. Breastfeeding: not recommended.
Contraindications
hypersensitivity to components; narrow-angle glaucoma; pheochromocytoma; history of neuroleptic malignant syndrome; concurrent use of monoamine oxidase inhibitors
Precautions and warnings
may cause sudden sleep onset; may impair ability to drive; monitor for impulsive behaviour
Serious side effects
neuroleptic malignant syndrome — requires immediate medical attention; rhabdomyolysis — requires immediate medical attention
Mechanism of action
Combines a dopamine precursor to restore levels, a peripheral decarboxylase inhibitor to prevent systemic breakdown, and a COMT inhibitor to extend the duration of the dopamine effect in the brain.
Stalevo
Utilized to manage neurological dysfunction to support motor control.
Editorial Notes
- Active ingredient(s): Carbidopa, Levodopa, Entacapone
- Listed indication(s): Parkinson’s Disease
Available option
- 90 tablets - 25/100/200 mg1124-25-100-200-mg-15628